Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes

NCT01364584 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Exenatide
DRUG: Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]